ライフサイエンスコーパス: nalbuphine

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 yl = oxymorphine > butorphanol = oxycodone = nalbuphine.

2 ent study, rats were trained to discriminate nalbuphine (3.2 mg/kg, s.c.) from saline in an operant c

3 imaging sessions subjects were administered nalbuphine (5 mg/70 kg) preceded by either saline (Sal-N

4 Nalbuphine, an agonist-antagonist kappa-opioid, produces

5 We found that both nalbuphine and butorphanol produced significantly greate

6 other predominantly kappa-opioid analgesics, nalbuphine and butorphanol; was compared in males and fe

7 dopa levels were determined with and without nalbuphine, and postmortem brain samples were subjected

8 ist pharmacophores (naltrexone, naloxone, or nalbuphine) at the other end.

9 Nalbuphine coadministered with levodopa was well tolerat

10 Striatal tissue analyses showed that nalbuphine cotherapy blocks several molecular correlates

11 nation, subjects were injected with a single nalbuphine dose (0.1-3.2 mg/kg) and given 30-min access

12 ism and reproducible LID received a range of nalbuphine doses or saline subcutaneously as: (1) monoth

13 e was no tolerance to the anti-LID effect of nalbuphine given chronically.

14 using the mixed agonist/antagonist analgesic nalbuphine in reducing LID and its molecular markers in

15 of clonidine, dexmedetomidine, ketamine and nalbuphine in the treatment of emergence delirium after

16 Nalbuphine induced functional connectivity between cauda

17 Given these findings, we suggest that nalbuphine interacts with a pain salience system, which

18 All patients received midazolam and nalbuphine intravenously.

19 Nalbuphine, like morphine in a previous study, attenuate

20 Nalbuphine monotherapy had no effect on motor disability

21 To examine the effect of nalbuphine or nalbuphine plus naloxone on activity in br

22 To examine the effect of nalbuphine or nalbuphine plus naloxone on activity in brain regions th

23 Naloxone pretreatment to nalbuphine produced changes in brain activity possess ch

24 Nalbuphine reduced LID in a dose-dependent manner by 48%

25 Nalbuphine reverses the molecular milieu in the striatum

26 Sucrose consumption did not alter nalbuphine's discriminative stimulus effects under these

27 sucrose consumption increased the potency of nalbuphine to produce its discriminative stimulus effect

28 -efficacy partial agonists buprenorphine and nalbuphine was increased in cells expressing RGS-insensi

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。